Home / MMIRF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MMIRF make money? Does MMIRF have pricing power? What's the Earnings Whisper? Will MMIRF profit more as the business scales? What is MMIRF's management track record? Is MMIRF's current price justified?

MedMira Inc.

$0.02 +$0.00 (+33.33%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$0.01

Day Range

$0.02$0.04

Year Range

$0$0.95

Market Cap

11.23M

AVG Volume

17.14K

Trailing/Forward PE

-15.91/-

PEG ratio

-0.35

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (CAD)

MMIRF Revenue (CAD) by quarter
Period	Revenue (CAD)
26 Q3	241.11K
26 Q2	24.54K
26 Q1	54.2K
25 Q4	50.67K
25 Q3	59.12K
25 Q2	69K
25 Q1	61.72K
24 Q4	64.46K
24 Q3	81.55K
24 Q2	148.7K

Net Income (CAD)

MMIRF Net Income (CAD) by quarter
Period	Net Income (CAD)
26 Q3	-483.5K
26 Q2	-658.59K
26 Q1	-813.02K
25 Q4	-751K
25 Q3	-983.44K
25 Q2	-1.2M
25 Q1	-1.3M
24 Q4	-1.18M
24 Q3	-780.15K
24 Q2	-590.79K

Operating Income (CAD)

MMIRF Operating Income (CAD) by quarter
Period	Operating Income (CAD)
26 Q3	-261.91K
26 Q2	-496.43K
26 Q1	-480.96K
25 Q4	-705.64K
25 Q3	-729.76K
25 Q2	-1.1M
25 Q1	-1.06M
24 Q4	-860.57K
24 Q3	-603.09K
24 Q2	-536.32K

EBITDA (CAD)

MMIRF EBITDA (CAD) by quarter
Period	EBITDA (CAD)
26 Q3	-186.99K
26 Q2	-421.25K
26 Q1	-405.9K
25 Q4	-648.92K
25 Q3	-649.68K
25 Q2	-874.68K
25 Q1	-978.49K
24 Q4	-733.04K
24 Q3	-547.89K
24 Q2	-479.82K

Cash Flows (CAD)

MMIRF Cash Flows (CAD) by quarter
Period	Cash Flows (CAD)
26 Q3	-150.58K
26 Q2	-268.11K
26 Q1	-254.94K
25 Q4	-373.18K
25 Q3	-920.57K
25 Q2	-717.76K
25 Q1	-997.55K
24 Q4	-1.51M
24 Q3	-950.25K
24 Q2	-540.04K

EPS (CAD)

MMIRF EPS (CAD) by quarter
Period	EPS (CAD)
26 Q3	-0
26 Q2	-0
26 Q1	-0
25 Q4	-0
25 Q3	-0
25 Q2	-0
25 Q1	-0
24 Q4	-0
24 Q3	-0
24 Q2	-0

Expenses (CAD)

MMIRF Expenses (CAD) by quarter
Period	Expenses (CAD)
26 Q3	275.49K
26 Q2	232.45K
26 Q1	451.2K
25 Q4	478.54K
25 Q3	580.62K
25 Q2	940.59K
25 Q1	877.11K
24 Q4	1.4M
24 Q3	458.3K
24 Q2	417.78K

Cash & Debt (CAD)

MMIRF Cash & Debt (CAD) by quarter
Period	Cash & Debt (CAD)
26 Q3	0
26 Q2	96.35K
26 Q1	0
25 Q4	14.91K
25 Q3	18.28K
25 Q2	295.62K
25 Q1	1.06M
24 Q4	2.1M
24 Q3	2.91M
24 Q2	853.82K

Debt ratios

MMIRF Debt ratios by quarter
Period	Debt ratios
26 Q3	-10.47
26 Q2	-8.15
26 Q1	-7.46
25 Q4	-3.39
25 Q3	-3.14
25 Q2	-2.93
25 Q1	-3.1
24 Q4	-3.24
24 Q3	-3.01
24 Q2	-4.39

Margins

MMIRF Margins by quarter
Period	Margins
26 Q3	-26.64%
26 Q2	-1011.32%
26 Q1	78.05%
25 Q4	62.01%
25 Q3	72.76%
25 Q2	66.15%
25 Q1	85.51%
24 Q4	58.04%
24 Q3	-177.56%
24 Q2	-100.85%

Return on Capital

MMIRF Return on Capital by quarter
Period	Return on Capital
26 Q3	1.97%
26 Q2	2.74%
26 Q1	3.48%
25 Q4	4.61%
25 Q3	4.57%
25 Q2	5.84%
25 Q1	6.73%
24 Q4	6.51%
24 Q3	4.63%
24 Q2	3.67%

Shares Outstanding

MMIRF Shares Outstanding by quarter
Period	Shares Outstanding
26 Q3	697.67M
26 Q2	697.67M
26 Q1	697.67M
25 Q4	697.67M
25 Q3	701.73M
25 Q2	701.73M
25 Q1	697.67M
24 Q4	697.67M
24 Q3	697.67M
24 Q2	698.09M

Book Value Per Share (CAD)

MMIRF Book Value Per Share (CAD) by quarter
Period	Book Value Per Share (CAD)
26 Q3	-0.04
26 Q2	-0.03
26 Q1	-0.03
25 Q4	-0.02
25 Q3	-0.03
25 Q2	-0.03
25 Q1	-0.03
24 Q4	-0.03
24 Q3	-0.02
24 Q2	-0.02

Total Assets (CAD)

MMIRF Total Assets (CAD) by quarter
Period	Total Assets (CAD)
26 Q3	3.4M
26 Q2	3.58M
26 Q1	3.6M
25 Q4	3.68M
25 Q3	3.78M
25 Q2	4.2M
25 Q1	4.99M
24 Q4	6.07M
24 Q3	6.36M
24 Q2	4.46M

Free Cash Flow Yield

MMIRF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-6.76%
Sep 26	-2.71%
Aug 26	-2.7%
Aug 26	-2.73%
Aug 26	-2.7%
Aug 26	-2.69%
Jul 26	-2.61%
Jul 26	-4.62%
Jul 26	-3.81%
Jul 26	-3.78%
Jul 26	-3.77%
Jun 26	-3.77%
Jun 26	-3.78%
Jun 26	-15.39%
Jun 26	-15.44%
May 26	-15.61%
May 26	-15.58%
May 26	-15.66%
May 26	-15.74%
May 26	-4.36%
Apr 26	-5.4%
Apr 26	-5.27%
Apr 26	-5.22%
Apr 26	-5.19%
Mar 26	-5.2%
Mar 26	-5.25%
Mar 26	-17.8%
Mar 26	-18.01%
Feb 26	-17.91%
Feb 26	-17.86%
Feb 26	-17.94%
Feb 26	-17.87%
Jan 26	-17.94%
Jan 26	-26.24%
Jan 26	-25.83%
Jan 26	-25.84%
Jan 26	-26.18%
Dec 25	-6.31%
Dec 25	-6.25%
Dec 25	-14.17%
Dec 25	-14.13%
Nov 25	-13.97%
Nov 25	-13.84%
Nov 25	-6.84%
Nov 25	-6.14%
Oct 25	-6.16%
Oct 25	-8.43%
Oct 25	-8.42%
Oct 25	-8.43%
Oct 25	-8.46%
Sep 25	-4.7%
Sep 25	-4.76%
Sep 25	-4.74%
Sep 25	-4.74%
Aug 25	-4.77%
Aug 25	-10.67%
Aug 25	-8.61%
Aug 25	-8.65%
Aug 25	-8.63%
Jul 25	-8.66%
Jul 25	-30.95%
Jul 25	-31.02%
Jul 25	-31.26%
Jun 25	-8.05%
Jun 25	-8.02%
Jun 25	-8.2%
Jun 25	-31.01%
May 25	-14.1%
May 25	-20.92%
May 25	-20.56%
May 25	-20.61%
May 25	-20.79%
Apr 25	-19.97%
Apr 25	-19.99%
Apr 25	-19.95%
Apr 25	-5.39%
Mar 25	-30.53%
Mar 25	-30.45%
Mar 25	-30.41%
Mar 25	-4.43%
Feb 25	-4.4%
Feb 25	-5.03%
Feb 25	-20.18%
Feb 25	-20.03%
Jan 25	-4.65%
Jan 25	-4.34%
Jan 25	-4.65%
Jan 25	-27.94%
Jan 25	-27.89%
Dec 24	-6.71%
Dec 24	-6.73%
Dec 24	-6.74%
Dec 24	-6.78%
Nov 24	-6.57%
Nov 24	-6.58%
Nov 24	-6.53%
Nov 24	-6.61%
Nov 24	-6.59%
Oct 24	-5.11%
Oct 24	-5.14%

Price to Sales

MMIRF Price to Sales by quarter
Period	Price to Sales
Sep 26	41.78
Sep 26	104.18
Aug 26	104.7
Aug 26	103.66
Aug 26	104.48
Aug 26	104.96
Jul 26	108.17
Jul 26	208.6
Jul 26	252.66
Jul 26	255.02
Jul 26	255.57
Jun 26	255.69
Jun 26	254.78
Jun 26	62.63
Jun 26	62.41
May 26	61.73
May 26	61.86
May 26	61.54
May 26	61.23
May 26	221.21
Apr 26	180.05
Apr 26	184.45
Apr 26	186.48
Apr 26	187.54
Mar 26	187.17
Mar 26	185.27
Mar 26	54.64
Mar 26	54
Feb 26	54.31
Feb 26	54.46
Feb 26	54.22
Feb 26	54.44
Jan 26	54.23
Jan 26	47.68
Jan 26	48.43
Jan 26	48.42
Jan 26	47.78
Dec 25	198.28
Dec 25	200.1
Dec 25	88.27
Dec 25	88.56
Nov 25	89.56
Nov 25	90.37
Nov 25	182.99
Nov 25	203.7
Oct 25	203.08
Oct 25	193.06
Oct 25	193.4
Oct 25	193.1
Oct 25	192.39
Sep 25	346.14
Sep 25	342.01
Sep 25	343.8
Sep 25	343.3
Aug 25	341.17
Aug 25	152.54
Aug 25	189.07
Aug 25	188.25
Aug 25	188.7
Jul 25	174.01
Jul 25	48.7
Jul 25	48.58
Jul 25	48.22
Jun 25	187.28
Jun 25	188.03
Jun 25	183.86
Jun 25	48.59
May 25	106.92
May 25	72.05
May 25	73.3
May 25	73.12
May 25	72.5
Apr 25	56.11
Apr 25	56.04
Apr 25	56.17
Apr 25	208
Mar 25	36.7
Mar 25	36.79
Mar 25	36.84
Mar 25	252.99
Feb 25	254.7
Feb 25	222.58
Feb 25	55.51
Feb 25	55.92
Jan 25	240.76
Jan 25	205.38
Jan 25	191.94
Jan 25	31.93
Jan 25	31.99
Dec 24	133.04
Dec 24	132.67
Dec 24	132.32
Dec 24	131.6
Nov 24	135.88
Nov 24	135.61
Nov 24	136.7
Nov 24	134.95
Nov 24	135.35
Oct 24	126.38
Oct 24	125.56

EV/EBITDA

MMIRF EV/EBITDA by quarter
Period	EV/EBITDA
Jan 22	736.52
Jan 22	753.34
Jan 22	1060.97
Jan 22	1026.57
Dec 21	878.5
Dec 21	730.16
Dec 21	675.25
Dec 21	812.06
Dec 21	617.45
Nov 21	525.29
Nov 21	538.79
Nov 21	529.19
Nov 21	578.35
Oct 21	559.1
Oct 21	161.84
Oct 21	168.15
Oct 21	167.28
Oct 21	199.95
Sep 21	199.99
Sep 21	220.31
Sep 21	189.06
Sep 21	178.09
Aug 21	231.61
Aug 21	178.46
Aug 21	148.12
Aug 21	161.17
Jul 21	155.71
Jul 21	381.44
Jul 21	397.04
Jul 21	423.08
Jul 21	436.24
Jun 21	438.85
Jun 21	467.31
Jun 21	500.46
Jun 21	506.26
May 21	511.7
May 21	577.77
May 21	548.57
May 21	600.13
Apr 21	2519.4
Apr 21	2730.82
Apr 21	2913.7
Apr 21	3194.26
Apr 21	3203.84
Mar 21	3207.24
Mar 21	3192.45
Mar 21	3477.28
Mar 21	3378.95
Feb 21	3470.46
Feb 21	3740.9
Feb 21	3767.62
Feb 21	4260.42
Jan 21	4020.64

Price/Operating Cashflow

MMIRF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Oct 21	393.64
Oct 21	411.16
Oct 21	408.75
Oct 21	499.49
Sep 21	499.61
Sep 21	556.06
Sep 21	469.23
Sep 21	438.78
Aug 21	587.43
Aug 21	439.79
Aug 21	355.52
Aug 21	391.77
Jul 21	376.6
Jul 21	375.19
Jul 21	392.84
Jul 21	422.29
Jul 21	437.18
Jun 21	440.14
Jun 21	472.33
Jun 21	509.84
Jun 21	516.39
May 21	522.55
May 21	597.3
May 21	564.26
May 21	622.59
Apr 21	810.99
Apr 21	885.03
Apr 21	949.08
Apr 21	1047.34
Apr 21	1050.7
Mar 21	1051.89
Mar 21	1046.71
Mar 21	1146.46
Mar 21	1112.02
Feb 21	1144.08
Feb 21	1238.79
Feb 21	1248.15
Feb 21	1420.74
Jan 21	1336.76

No video analysis for this stock yet. Request one from our team.

News: MMIRF

accessnewswire.com · 29 Jun 2026

MedMira Reports Third Quarter Results FY2026

HALIFAX, NS / ACCESS Newswire / June 29, 2026 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended April 30, 2026. Corporate update During Q3 FY2026, the Company continued to advance the regulatory approval process for its Multiplo® Complete Syphilis (TP/nTP) Antibody Test (Multiplo® TP/nTP).

AI Analysis

MedMira Inc.

Video analysis: MMIRF

News: MMIRF

MedMira Reports Third Quarter Results FY2026

Similar companies